Lindbrook Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-208
| Closed | -$38K | – | 2080 |
|
|
2021
Q2 | $38K | Hold |
208
| – | – | 0.01% | 562 |
|
|
2021
Q1 | $32K | Buy |
208
+27
| +15% | +$4.15K | 0.01% | 583 |
|
|
2020
Q4 | $28K | Buy |
181
+12
| +7% | +$1.86K | 0.01% | 584 |
|
|
2020
Q3 | $19K | Buy |
169
+10
| +6% | +$1.12K | 0.01% | 634 |
|
|
2020
Q2 | $18K | Buy |
159
+55
| +53% | +$6.23K | 0.01% | 655 |
|
|
2020
Q1 | $9K | Buy |
104
+27
| +35% | +$2.34K | ﹤0.01% | 811 |
|
|
2019
Q4 | $8K | Sell |
77
-92
| -54% | -$9.56K | ﹤0.01% | 994 |
|
|
2019
Q3 | $17K | Buy |
169
+2
| +1% | +$201 | 0.01% | 767 |
|
|
2019
Q2 | $21K | Sell |
167
-15
| -8% | -$1.89K | 0.01% | 689 |
|
|
2019
Q1 | $24K | Sell |
182
-4
| -2% | -$527 | 0.01% | 639 |
|
|
2018
Q4 | $18K | Buy |
+186
| New | +$18K | 0.01% | 656 |
|